BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35925390)

  • 1. TIMP3::ALK fusions characterize a distinctive myxoid fibroblastic tumor of the vocal cords: a report of 7 cases.
    Klubíčková N; Michal M; Agaimy A; Zidar N; Pavlovský M; Yorita K; Grossmann P; Hájková V; Ptáková N; Šteiner P; Michal M
    Virchows Arch; 2022 Nov; 481(5):721-729. PubMed ID: 35925390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vocal cord inflammatory myofibroblastic tumor with mucoid deposits harboring TIMP3-ALK fusion: A potential diagnostic pitfall.
    Yorita K; Togashi Y; Nakagawa H; Miyazaki K; Sakata S; Baba S; Takeuchi K; Hayashi Y; Murakami I; Kuroda N; Oda Y; Kohashi K; Yamada Y; Kiyozawa D; Michal M; Michal M
    Pathol Int; 2019 Jun; 69(6):366-371. PubMed ID: 31215130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions With IGFBP5 and THBS1.
    Haimes JD; Stewart CJR; Kudlow BA; Culver BP; Meng B; Koay E; Whitehouse A; Cope N; Lee JC; Ng T; McCluggage WG; Lee CH
    Am J Surg Pathol; 2017 Jun; 41(6):773-780. PubMed ID: 28490045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions.
    Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA
    Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion.
    Cheek EH; Fadra N; Jackson RA; Davila JI; Sukov WR; Uckerman MT; Clayton A; Keeney GL; Halling KC; Torres-Mora J; Schoolmeester JK
    Hum Pathol; 2020 Mar; 97():29-39. PubMed ID: 31917155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.
    Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS
    Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.
    Mariño-Enríquez A; Wang WL; Roy A; Lopez-Terrada D; Lazar AJ; Fletcher CD; Coffin CM; Hornick JL
    Am J Surg Pathol; 2011 Jan; 35(1):135-44. PubMed ID: 21164297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.
    Subbiah V; McMahon C; Patel S; Zinner R; Silva EG; Elvin JA; Subbiah IM; Ohaji C; Ganeshan DM; Anand D; Levenback CF; Berry J; Brennan T; Chmielecki J; Chalmers ZR; Mayfield J; Miller VA; Stephens PJ; Ross JS; Ali SM
    J Hematol Oncol; 2015 Jun; 8():66. PubMed ID: 26062823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel case of cutaneous myxoid spindle cell neoplasm with FMR1-ALK gene fusion and CD34/S100 co-expression.
    Kasago I; Aypar U; Sukhadia P; Vanderbilt C; Ladanyi M; Hurd T; Pulitzer M
    J Cutan Pathol; 2023 Jun; 50(6):505-510. PubMed ID: 36325885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
    Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
    Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanocytic Myxoid Spindle Cell Tumor With ALK Rearrangement (MMySTAR): Report of 4 Cases of a Nevus Variant With Potential Diagnostic Challenge.
    Perron E; Pissaloux D; Charon Barra C; Karanian M; Lamant L; Parfait S; Alberti L; de la Fouchardière A
    Am J Surg Pathol; 2018 May; 42(5):595-603. PubMed ID: 29635259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic features of extrapulmonary inflammatory myofibroblastic tumor].
    Li H; Shen Q; Xia Q; Shi S; Zhang R; Yu B; Ma H; Lu Z; Wang X; He Y; Zhou X; Rao Q
    Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):370-4. PubMed ID: 25208985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
    Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R
    Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus.
    Mohammad N; Haimes JD; Mishkin S; Kudlow BA; Leong MY; Chew SH; Koay E; Whitehouse A; Cope N; Ali RH; Köbel M; Stewart CJR; McCluggage WG; Lee CH
    Am J Surg Pathol; 2018 Oct; 42(10):1353-1359. PubMed ID: 30015720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelioid inflammatory myofibroblastic sarcoma: a clinicopathological, immunohistochemical and molecular cytogenetic analysis of five additional cases and review of the literature.
    Yu L; Liu J; Lao IW; Luo Z; Wang J
    Diagn Pathol; 2016 Jul; 11(1):67. PubMed ID: 27460384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myxoid Leiomyosarcoma of the Uterus: A Clinicopathologic Analysis of 30 Cases and Review of the Literature With Reappraisal of Its Distinction From Other Uterine Myxoid Mesenchymal Neoplasms.
    Parra-Herran C; Schoolmeester JK; Yuan L; Dal Cin P; Fletcher CD; Quade BJ; Nucci MR
    Am J Surg Pathol; 2016 Mar; 40(3):285-301. PubMed ID: 26866354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory myofibroblastic tumor of the uterus - case report.
    Štiková Z; Ptáková N; Horáková M; Kosťun J; Ondič O
    Cesk Patol; 2019; 55(4):239-243. PubMed ID: 31842556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course.
    Parra-Herran C; Quick CM; Howitt BE; Dal Cin P; Quade BJ; Nucci MR
    Am J Surg Pathol; 2015 Feb; 39(2):157-68. PubMed ID: 25321329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory myofibroblastic tumor of the uterus: a clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum.
    Bennett JA; Nardi V; Rouzbahman M; Morales-Oyarvide V; Nielsen GP; Oliva E
    Mod Pathol; 2017 Oct; 30(10):1489-1503. PubMed ID: 28664932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EWSR1-SMAD3-rearranged Fibroblastic Tumor: An Emerging Entity in an Increasingly More Complex Group of Fibroblastic/Myofibroblastic Neoplasms.
    Michal M; Berry RS; Rubin BP; Kilpatrick SE; Agaimy A; Kazakov DV; Steiner P; Ptakova N; Martinek P; Hadravsky L; Michalova K; Szep Z; Michal M
    Am J Surg Pathol; 2018 Oct; 42(10):1325-1333. PubMed ID: 29957732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.